CBD Could Help Slow Progression of ALS According to Study
According to a new study in The Journal of General Practice, as Reported in The Daily Chronic, CBD could help slow the progression of ALS/Lou Gehrig's Disease.
The co-administration of cannabidiol (CBD) with the prescription drug riluzole (marketed as Rilutek) is associated with the delayed onset of amyotrophic lateral sclerosis (ALS aka Lou Gehrig’s disease), according to a case report published in the Journal of General Practice.
A researcher reported that the administration of 300mg of CBD twice daily was associated with the limited progression of various ALS symptoms in a single patient.
For more information, check out The Daily Chronic, or The Journal of General Practice [warning: PDF].